Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy
- PMID: 19147690
- DOI: 10.1634/theoncologist.2008-0281
Commentary: Sorafenib use in patients with advanced hepatocellular carcinoma and underlying Child-Pugh B cirrhosis: evidence and controversy
Comment on
-
Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis.Oncologist. 2009 Jan;14(1):70-6. doi: 10.1634/theoncologist.2008-0191. Epub 2009 Jan 14. Oncologist. 2009. PMID: 19144684
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
